health

Ebola reminder of urgent need to finish pandemic treaty: WHO chief

Ebola reminder of urgent need to finish pandemic treaty: WHO chief

Deadly outbreaks like the Ebola epidemic raging in the Democratic Republic of Congo show the urgent need to complete an international pandemic treaty, the World Health Organization chief said Monday. As the ninth meeting towards finalising the deal opened in Geneva Monday, WHO chief Tedros Adhanom Ghebreyesus called on countries to “finish the job”.

Deadly outbreaks like the Ebola epidemic raging in the Democratic Republic of Congo show the urgent need to complete an international pandemic treaty, the World Health Organization chief said Monday. Wealthy countries and developing nations remain at loggerheads over how an agreement, adopted last year as a framework to handle future Covid-like pandemics, will work in practice.

As the ninth meeting towards finalising the deal opened in Geneva Monday, WHO chief Tedros Adhanom Ghebreyesus called on countries to “finish the job”. Pointing to several recent deadly disease outbreaks, he stressed that completing a pandemic treaty was “about protecting people”. “A pathogen threat anywhere can become a threat everywhere, to people of every country,” he said, according to a written version of his statement.

“The outbreak of hantavirus earlier this year, and the ongoing Ebola epidemic in DRC remind us of this threat.” He was referring to the hantavirus outbreak that killed three people on a cruise ship in April and the latest Ebola outbreak, declared in May, which has killed nearly 5,000 people out of more than 10,000 infected mostly in the DRC. It was vital, Tedros said, that the world learn the overarching lesson of the Covid-19 pandemic: “no country can protect itself from pandemics by acting alone”.

When countries agreed in May 2025 to a Pandemic Agreement, they left out the tricky issue of how the key mechanism would operate to get the deal over the line. The agreement’s Pathogen Access and Benefit-Sharing (PABS) system covers how to share access to pathogens with pandemic potential, as well as benefits derived from them such as vaccines, tests and treatments.

“PABS is the last remaining piece of our puzzle,” Tedros said. During the Covid pandemic, he highlighted that “the world developed vaccines in record time, but too many countries were left waiting while others secured far more than they needed”. “That inequity cost lives, prolonged the pandemic and increased the risk of new variants emerging.” Completing the final piece of the pandemic treaty, he insisted, was “the key that will unlock the door to a safer future”.

  • ebola
  • treaty
  • pandemic
  • chief
  • country
  • outbreak
  • need
  • people

Summaries and tags are generated automatically. Stay informed with VidiaNews.

Related news

Experts on why your back hurts – and what to do about it
health

Experts on why your back hurts – and what to do about it

Are you one of 600 million people with lower back pain? The World Health Organization (WHO) reports that lower back pain is the leading cause of disability worldwide, with cases projected to rise to more than 800 million by 2050, largely as populations grow and age.

Read →
Six Ebola patients recover as Kenya records 18 days without new infection
health

Six Ebola patients recover as Kenya records 18 days without new infection

NAIROBI,Kenya, Nov 6- Kenya has discharged six patients who had contracted the Ebola virus, with only one remaining under treatment, as the country records 18 consecutive days without a new infection. In a statement marking Day 32 of the outbreak, Director-General for Health Dr Patrick Amoth said the total number of confirmed cases remained at nine, with all infections linked to a single known chain of transmission.

Read →
Ebola Patient Flown To UK From DR Congo
health

Ebola Patient Flown To UK From DR Congo

A UK medic who tested positive for Ebola while working on the outbreak of the disease in the Democratic Republic of Congo has been flown to London for treatment, the government said Thursday. The British government said that the UK medic is now being treated at the Royal Free Hospital in London.

Read →
Rwanda launches Africa’s first trial of long-acting malaria prevention injection
health

Rwanda launches Africa’s first trial of long-acting malaria prevention injection

NAIROBI, Kenya, Nov 6-Rwanda has launched Africa’s first clinical trial of a long-acting injectable drug for malaria prevention, marking a potential shift in how the disease is prevented as drug resistance and climate change threaten progress against the mosquito-borne illness. The Phase 1b trial, launched by Medicines for Malaria Venture (MMV) in partnership with Rwandan health research organisation Rinda Ubuzima, will assess the safety and tolerability of MMV371, an experimental drug designed to provide extended protection against malaria through a single injection.

Read →